Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

465
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
465
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

434
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
434
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.4K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

656
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
656
Clinical Trials01:16

Clinical Trials

11.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Postoperative imaging following spinal surgery for traumatic injuries].

Radiologie (Heidelberg, Germany)·2025
Same author

Effects of glucagon as a neurohormone on the central nervous system and glucose homeostasis.

European review for medical and pharmacological sciences·2024
Same author

[COVID-19: neurological manifestations-update : What we know so far].

Der Radiologe·2021
Same author

A new and reliable landmark in parotid surgery: tragomastoid groove (Akil Groove).

European review for medical and pharmacological sciences·2021
Same author

[Nonaccidental traumatic brain injury in infants and children].

Der Radiologe·2021
Same author

[Spontaneous craniocervical dissection].

Der Radiologe·2021

Related Experiment Video

Updated: Mar 28, 2026

The Stroke Preclinical Assessment Network Multi-laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
05:46

The Stroke Preclinical Assessment Network Multi-laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo

Published on: December 19, 2025

383

[Mechanical Thrombectomy - Recent Trials].

U Yilmaz1, R Mühl-Benninghaus2

  • 1Klinik für Diagnostische und Interventionelle Neuroradiologie, Universitätsklinikum des Saarlandes, Kirrbergerstraße, 66424, Homburg/Saar, Deutschland. umut.yilmaz@uks.eu.

Der Radiologe
|December 24, 2015
PubMed
Summary
This summary is machine-generated.

In 2015, new stroke therapies emerged beyond IV rtPA. Five trials (MR CLEAN, ESCAPE, EXTEND IA, SWIFT PRIME, REVASCAT) demonstrated new evidence-based recanalizing treatments for ischemic stroke.

Keywords:
Mechanical thrombektomyStent retrieverStroke

More Related Videos

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

3.3K
Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

22.5K

Related Experiment Videos

Last Updated: Mar 28, 2026

The Stroke Preclinical Assessment Network Multi-laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
05:46

The Stroke Preclinical Assessment Network Multi-laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo

Published on: December 19, 2025

383
An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

3.3K
Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

22.5K

Area of Science:

  • Neurology
  • Interventional Neurology
  • Stroke Medicine

Background:

  • Intravenous recombinant tissue plasminogen activator (IV rtPA) was the sole evidence-based recanalizing therapy for ischemic stroke prior to 2015.
  • The year 2015 marked a significant advancement in stroke treatment with the publication of five major prospective randomized trials.

Purpose of the Study:

  • To review and synthesize the findings from five key prospective randomized trials.
  • To highlight the emergence of new evidence-based recanalizing treatments for ischemic stroke.

Main Methods:

  • Review of results from five prospective randomized trials: MR CLEAN, ESCAPE, EXTEND IA, SWIFT PRIME, and REVASCAT.
  • Analysis of data pertaining to recanalizing therapies for ischemic stroke.

Main Results:

  • The five reviewed trials provided new evidence for recanalizing treatments in ischemic stroke.
  • These trials expanded treatment options beyond the previously established IV rtPA.

Conclusions:

  • 2015 represents a pivotal year in stroke therapy development.
  • New recanalizing treatments have been established as evidence-based options for ischemic stroke patients.